Marijuana Times reports
“The NZ government’s approval of this trial to assess a new cannabis gel for treatment of seizures, is an important step forward in the NZ government’s recognition of the potential of cannabis and various cannabinoids for medical purposes,” said Sue Grey, a New Zealand lawyer. Grey has recently been flooded with requests from medical marijuana patients in need of legal defense.
It’s not the norm, as the availability of cannabinoids for therapeutic use in New Zealand is slim to none.
Abe Gray is a radio personality, researcher, and curator of New Zealand’s only cannabis museum. He’s skeptical, at best, that this will change the mind of the Minister of Health.
“The current approach of the NZ Ministry of Health tends to ignore the evidence from people who have successfully used various cannabis products.” He added, “My experience indicates that the real problem is not the lack of evidence, but the lack of resources to collect, assess and circulate that evidence in a transparent way and a lack of education of doctors and other medical experts on how and why cannabinoids work and how they can most effectively be used.”
Full Article: https://www.marijuanatimes.org/new-zealand-participates-in-clinical-trials-for-epilepsy/
